Hyoscyamine Sulfate TAB

HYOSCYAMINE SULFATE ORAL HUMAN PRESCRIPTION DRUG

Hyoscyamine Sulfate TAB is an FDA drug label for the active ingredient HYOSCYAMINE SULFATE manufactured by REMEDYREPACK INC. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20260609.

Generic name
HYOSCYAMINE SULFATE
Manufacturer
REMEDYREPACK INC.
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Dosage form
N/A
NDC
70518-3847
Application
N/A
Label effective
20260609

About this product

Hyoscyamine Sulfate TAB is an FDA-registered drug product whose active ingredient is HYOSCYAMINE SULFATE. It is labelled by REMEDYREPACK INC. taken by oral and marketed as a human prescription drug product. Identifiers on file: NDC 70518-3847, label effective 20260609. It is one of 11 FDA drug label records sharing the active ingredient HYOSCYAMINE SULFATE. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

What it is used for

Across FDA labelling, products containing HYOSCYAMINE SULFATE are most often described in connection with: functional intestinal, disorders reduce, seen mild, control gastric, secretion visceral, hypermotility cystitis, associated abdominal, cramps along. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

Indications & Usage

INDICATIONS AND USAGE This product may be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries and diverticulitis. It can also be used to control gastric secretion, visceral spasm and hypermotility in cystitis, pylorospasm and associated abdominal cramps. Along with appropriate analgesics, this product is indicated in symptomatic relief of biliary and renal colic and as a drying agent in the relief of symptoms of acute rhinitis. This product is effective as adjunctive therapy in the treatment of peptic ulcer and irritable bowel syndrome, acute enterocolitis and other functional gastrointestinal disorders.

Dosage & Administration

DOSAGE AND ADMINISTRATION Dosage may be adjusted according to the condition and severity of symptoms. May be taken with or without water. Adults and adolescents 12 years of age and older: 1 to 2 tablets orally three or four times a day, thirty minutes to one hour before meals and at bedtime. Dosage may be increased to every four hours as needed. Do not exceed 12 tablets in 24 hours. Note: Geriatric patients may be more sensitive to the effects of the usual adult dose.

Contraindications

CONTRAINDICATIONS Glaucoma, obstructive uropathy, obstructive diseases of the gastrointestinal tract, paralytic ileum, intestinal atony of elderly or debilitated patients, unstable cardiovascular status, severe ulcerative colitis, toxic megacolon, myasthenia gravis, and myocardial ischemia. This product is not recommended for use in children under twelve years of age.

Warnings

WARNINGS Heat prostration can occur with drug use in the event of high environmental temperature. Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy; in this instance, treatment would be inappropriate and possibly harmful. This product may cause drowsiness or blurred vision. Patients taking this product should be warned not to engage in activities requiring mental alertness such as operating a motor vehicle or other machinery or to perform hazardous tasks while taking this drug.

Adverse Reactions

ADVERSE REACTIONS Not all of the following adverse reactions have been reported with hyoscyamine sulfate. The following adverse reactions have been reported for pharmacologically similar drugs with anticholinergic/ antispasmodic action. Adverse reactions may include dryness of the mouth, urinary hesitancy and retention; blurred vision; tachycardia; palpitations; mydriasis; cycloplegia; increased ocular tension; loss of taste; headache; nervousness; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; impotence; suppression of lactation; constipation; bloated feeling; allergic reactions or drug idiosyncrasies; urticaria and other dermal manifestations; ataxia; speech disturbance; some degree of mental confusion and/or excitement (especially in elderly persons); and decreased sweating.

More products with the same ingredient

HYOSCYAMINE SULFATE

Hyoscyamine ER

Mylan Pharmaceuticals Inc. View label

Hyoscyamine Sulfate

Bryant Ranch Prepack View label

Hyoscyamine Sulfate

Granulation Technology, Inc. View label

Hyoscyamine Sulfate

Bryant Ranch Prepack View label

Hyoscyamine Sulfate

Bryant Ranch Prepack View label

Hyoscyamine Sulfate

PD-Rx Pharmaceuticals, Inc. View label

Hyoscyamine Sulfate

Granulation Technology, Inc. View label

Hyoscyamine Sulfate

Bryant Ranch Prepack View label

How products containing HYOSCYAMINE SULFATE compare

FDA lists 11 drug label records with HYOSCYAMINE SULFATE as the active ingredient. The most common dosage forms and the manufacturers with the most records are summarised below; strengths, pack sizes and inactive ingredients can still differ between apparently similar products.

Dosage formProductsManufacturerProducts
— — Bryant Ranch Prepack 5
— — Granulation Technology, Inc. 2
— — Mylan Pharmaceuticals Inc. 1
— — PD-Rx Pharmaceuticals, Inc. 1
— — REMEDYREPACK INC. 1

Recall and safety notices

5 FDA recall record(s) match this product name or manufacturer. A match means the firm or product name appears in the enforcement report; confirm lot numbers and dates against the official FDA notice before acting.

RecallProductFirmClassStatusReported
D-0411-2025 Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02 RemedyRePack Inc. Class II Ongoing 20250514
D-0378-2025 Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00 RemedyRepack Inc. Class II Ongoing 20250430
D-0217-2025 Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00. RemedyRepack Inc. Class II Terminated 20250212
D-0165-2025 Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA RemedyRepack Inc. Class II Ongoing 20250101
D-0611-2024 Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1203-03 RemedyRepack Inc. Class II Terminated 20240724

Frequently asked questions

What is Hyoscyamine Sulfate TAB used for?
INDICATIONS AND USAGE This product may be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries and diverticulitis. It can also be used to control gastric secretion, visceral spasm and hypermotility in cystitis, pylorospasm and associated abdominal cramps. Along with appropriate analgesics, this product is indicated in symptomatic relief of biliary and …

Who makes Hyoscyamine Sulfate TAB?
REMEDYREPACK INC. is the labeler of record for Hyoscyamine Sulfate TAB. 11 FDA label records share the active ingredient HYOSCYAMINE SULFATE, so generic and branded versions may come from different companies; the manufacturer named on your pack is the one that matters for any enquiry.

What form does Hyoscyamine Sulfate TAB come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is Hyoscyamine Sulfate TAB prescription or over-the-counter?
The FDA label for this product is recorded as human prescription drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Are there other products containing HYOSCYAMINE SULFATE?
Yes. 11 FDA drug label records list HYOSCYAMINE SULFATE as the active ingredient. Products with the same active ingredient can usually be substituted only when a prescriber or pharmacist confirms it is appropriate.

Has Hyoscyamine Sulfate TAB been recalled?
5 FDA recall record(s) match this product name or manufacturer. Review the recall and safety notices section on this page and confirm lot numbers against the official FDA enforcement report.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.

This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.